NanoVibronix Inc (NAOV) Stock
NAOV is no longer traded. NanoVibronix was delisted from the Nasdaq in December 2025.
Prices on this page are historical; the last trade was December 15, 2025 at $3.87.
NanoVibronix stock price history
NAOV final trading statistics
- Final close
- $3.87
- Final trading day
- Dec 15, 2025
- Market cap at delisting
- $4.21M
- Shares outstanding
- 1.09M
- Final 52-week range
- $0.20 – $17.40
- Avg. volume (final 3 mo.)
- 115,516
- All-time high (split-adj.)
- $16104.00 · Oct 2017
- All-time low (split-adj.)
- $3.74 · Nov 2025
- Return since IPO
- -99.9%
- Beta
- 2.06
- Book value / share
- $42.00
- Price / book
- 0.09
NanoVibronix annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $2.56M | -$3.7M | -$5.05 |
| FY2023 | $2.28M | -$3.7M | -$45.44 |
| FY2022 | $752.0K | -$5.4M | -$4.04 |
| FY2021 | $1.70M | -$14.3M | -$0.48 |
| FY2020 | $623.0K | -$4.3M | -$0.62 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About NanoVibronix Inc
NanoVibronix, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Tyler, Texas.
NanoVibronix stock FAQ
What happened to NanoVibronix stock?
NanoVibronix stock was delisted from the Nasdaq. Its final close was $3.87 on December 15, 2025.
Is NAOV stock still trading?
No. NAOV was delisted from the Nasdaq in December 2025 and no longer trades on a U.S. exchange.
What was the last price of NAOV stock?
NAOV closed at $3.87 on its final trading day, December 15, 2025, for a market value of about $4.21M.
What were NanoVibronix's revenue and earnings in its last full fiscal year?
NanoVibronix reported revenue of $2.56M and net income of -$3.7M in fiscal 2024, its last full year as a public company.
When did NanoVibronix go public?
NanoVibronix Inc stock began trading on June 27, 2017.